Wells Fargo & Company »

Orchard Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Orchard Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Orchard Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Orchard Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Orchard Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $19k 1.2k 16.45
2023-09-30 $9.7k 1.3k 7.73
2023-06-30 $59k 11k 5.21

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Orchard Therapeutics

Blue Owl Capital Holdings
Beryl Capital Management
Federated Investors
LMR Partners
Tudor Investment Corporation
Millennium Management
Goldman Sachs Group
CSS
ADAR1 Capital Management
Bck Capital Management
Jane Street
Jpmorgan Chase & Co
Hrt Financial
PenderFund Capital Management
Gts Securities

View all funds holding Orchard Therapeutics